Specifically, a significant increase in circulating CD4+ and CD8+ T lymphocytes was found upon recognition of leukemia-associated antigens (LAA) suggesting ecto-CALR and ICD stimulation as a potential strategy to improve clinical patients’ outcomes in AML [60,61]. This evidence concerns the gene CD8A and acute myeloid leukemia.